logo

Arena Pharmaceutical Inc. (ARNA)



Trade ARNA now with
  Date
  Headline
5/21/2019 7:31:29 AM Corvidia Therapeutics Appoints Preston Klassen To Board
5/17/2019 8:32:47 AM Arena Pharma Initiates Sites For ELEVATE UC Phase 3 Global Program To Evaluate Etrasimod 2 Mg
5/8/2019 4:06:14 PM Arena Pharma Q1 EPS $12.10 Vs. Loss $0.80 Year Ago
3/8/2019 8:31:15 AM Arena Pharma Presented New Phase 2 Data For Etrasimod And Olorinab
2/26/2019 4:02:46 PM Arena Pharmaceuticals Q4 EPS $1.35 Vs Loss $0.35 Last Year
1/24/2019 8:02:26 PM United Therapeutics Announces Closing Of License Agreement With Arena Pharmaceuticals For Ralinepag
1/7/2019 8:32:37 AM Arena Reports Positive Data From Open-label Extension Of Phase 2 OASIS Trial Of Etrasimod
12/17/2018 8:30:51 AM Arena Pharmaceuticals Appoints Manmeet Soni As A Non-executive Director
11/26/2018 8:37:40 AM Arena Appoints Robert Lisicki As EVP And Chief Commercial Officer And Paul Audhya SVP, Medical Affairs
11/7/2018 4:06:12 PM Arena Pharmaceuticals Q3 Loss/share $0.70 Vs. Loss $0.86 Year Ago